Akari Therapeutics (AKTX)
0.90
-0.04 (-3.95%)
At close: Mar 04, 2025, 11:48 AM
Akari Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 3.85M | 13.25M | 9.36M | 14.06M | 5.73M | 5.97M | 28.11M | 34.1M | 68.92M | 6.22M | 7.66M | 1.1M | 6K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.02M | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 521.83K | 142.24K | 143.67K | 142.08K | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | 0.00 | n/a | -0.00 | 585K | 142.24K | 142.17K | 142.08K | -59.42 | n/a | n/a | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6K | 12K | 21K |
| Inventory | n/a | -2.49M | n/a | -521.88K | -1.03M | -2.01M | n/a | n/a | -1.87K | n/a | n/a | n/a | n/a |
| Other Current Assets | 496K | 564.79K | 2.26M | 521.88K | 712.98K | 2.01M | 1.41M | 1.51M | 728.13K | 7.78K | n/a | 2K | n/a |
| Total Current Assets | 4.34M | 13.81M | 11.63M | 17.57M | 10.27M | 16.4M | 28.81M | 45.63M | 69.66M | 6.43M | 7.83M | 1.12M | 27K |
| Property-Plant & Equipment | n/a | n/a | n/a | n/a | 5K | 20K | 55.9K | 58.36K | 40.51K | 49K | n/a | 2K | n/a |
| Goodwill & Intangibles | 14K | 16.88K | 22.93K | 27K | 30K | 33K | 39.12K | 39.37K | 52.48K | 59.42 | 67.60 | n/a | n/a |
| Total Long-Term Assets | 14K | 16.88K | 22.93K | 27K | 35K | 53K | 237.26K | 239.9K | 235.07K | 49K | 67.60 | 2K | n/a |
| Total Assets | 4.36M | 13.83M | 11.65M | 17.59M | 10.31M | 16.45M | 29.05M | 45.87M | 69.89M | 6.48M | 7.83M | 1.12M | 27K |
| Account Payables | 1.67M | 947K | 1.79M | 3.38M | 1.23M | 1.59M | 1.97M | 2.21M | 4.32M | 555.53K | 652K | 1.7M | 1.38M |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -533.6 | -112.52 | n/a | n/a |
| Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 533.61 | n/a | 898K | n/a |
| Other Current Liabilities | 2.91M | 11.09M | 4.3M | 1.84M | 5.24M | 3.33M | 9.88M | 9.5M | 16.8M | 802.94K | 579K | 1.25M | 857K |
| Total Current Liabilities | 4.58M | 12.04M | 6.09M | 5.22M | 5.46M | 3.08M | 9.02M | 11.71M | 21.12M | 1.36M | 1.23M | 3.85M | 2.24M |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 48K | 56.36K | 49.07K | n/a | 787K | 630K | 60K |
| Total Long-Term Liabilities | n/a | 946.66K | 4.3M | n/a | 1.01M | n/a | 48K | 56.36K | 49.07K | 268K | 787K | 630K | 276K |
| Total Liabilities | 4.58M | 12.04M | 6.09M | 5.22M | 6.47M | 3.08M | 9.07M | 11.77M | 21.17M | 1.63M | 2.02M | 4.48M | 2.51M |
| Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 533.61 | 112.53 | 898K | n/a |
| Common Stock | 1.32M | 744.49K | 475.97K | 385K | 31.99M | 23.65M | 22.93M | 18.34M | 18.34M | 927K | 675K | 245K | 225K |
| Retained Earnings | -227.46M | -217.45M | -199.71M | -156.63M | -138.24M | -116.47M | -107.51M | -74.94M | -56.8M | -30.19M | -20.54M | -16.92M | -12.62M |
| Comprehensive Income | 51.15M | -770.84K | -540.97K | -10.94M | -12.24M | -12.25M | -236.25K | -280.1K | 156.48K | -18K | -10K | -11K | -9K |
| Shareholders Equity | -229K | 1.79M | 5.55M | 12.38M | 3.84M | 13.38M | 19.98M | 34.1M | 48.72M | 4.85M | 5.81M | -3.36M | -2.48M |
| Total Investments | n/a | n/a | n/a | n/a | n/a | 521.83K | 142.24K | 10.02M | 142.08K | n/a | n/a | n/a | n/a |